Search Results (1468)
Click the Why column to see why an item matched the search.

MatchTypeWhy
Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers.Academic Article Why?
Feng, HuiPerson Why?
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.Academic Article Why?
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.Academic Article Why?
The Use of An EHR Patient Portal (Mychart-Epic) in Patients With Inflammatory Bowel DiseaseAcademic Article Why?
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness.Academic Article Why?
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas.Academic Article Why?
Horsburgh, C.Person Why?
Editorial: Mycobacteria-Host Interactions: Genetics, Immunity, Pathology.Academic Article Why?
Defining the Role of Glutamine Anaplerosis in High Risk MYCN-Driven NeuroblastomaGrant Why?
Targeting CKLF as an Immunotherapeutic Approach to Treat MYCN-driven High-risk NeuroblastomaGrant Why?
c-myc is required for osteoclast differentiation.Academic Article Why?
Macrophages, mycobacteria and HIV: the role of cytokines in determining mycobacterial virulence and regulating viral replication.Academic Article Why?
UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response.Academic Article Why?
Comparative analysis of Mycobacterium and related Actinomycetes yields insight into the evolution of Mycobacterium tuberculosis pathogenesis.Academic Article Why?
First Prev Page of 98 Next Last Per PageĀ 
Highlights
Search Criteria
  • MYC
Filter by Type